搜索临床试验以:SHR-1210 plus Anlotinib
总计265个结果
-
Huazhong University of Science and Technology主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest Hospital未知化疗效果 | KRAS基因突变 | NSCLC IV期 | PD-1抗体
-
Hospital of Stomatology, Wuhan UniversityJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Huazhong University of Science and Technology尚未招聘
-
Zhou FuxiangHubei Cancer Hospital; Henan Provincial People's Hospital; Huangshi Central Hospital, China招聘中
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
Guangzhou Institute of Respiratory DiseaseJiangsu HengRui Medicine Co., Ltd.; BGI-Shenzhen完全的
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing Friendship Hospital 和其他合作者尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Peking Union Medical College Hospital招聘中
-
RenJi HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Henan Cancer HospitalFirst Affiliated Hospital Xi'an Jiaotong University招聘中
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Fudan University招聘中乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | HER2 阴性乳腺癌 | 激素受体阳性肿瘤 | 激素受体阴性肿瘤 | 早期乳腺癌 | 三阴性乳腺癌 (TNBC)中国
-
Hunan Cancer HospitalHenan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Medical University of GrazJuvenile Diabetes Research Foundation招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Hunan Cancer HospitalFuzhou Pulmonary Hospital of Fujian; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Tomsk National Research Medical Center of the Russian...完全的
-
Shanghai Changzheng Hospital未知
-
Shanghai Changzheng Hospital完全的